Application of white blood cell SPECT/CT to predict remission after a 6 or 12 week course of antibiotic treatment for diabetic foot osteomyelitis

Diabetologia. 2017 Dec;60(12):2486-2494. doi: 10.1007/s00125-017-4417-x. Epub 2017 Sep 2.

Abstract

Aims/hypothesis: Diabetic foot osteomyelitis is a major risk factor for amputation. Medical treatment allows remission in 53-82% of cases. However, the optimal duration of antibiotic therapy remains controversial as a validated marker of osteomyelitis remission is lacking. The aim of this cohort study was to assess prospectively the remission rate of diabetic foot osteomyelitis medically treated using white blood cell (WBC)-single-photon emission computed tomography (SPECT)/computed tomography (CT) as a predictive marker of remission.

Methods: Individuals with diabetic foot osteomyelitis that was non-surgically treated between April 2014 and December 2015 were included. All participants were treated with antibiotics alone. WBC-SPECT/CT was performed at 6 weeks and antibiotic treatment discontinued if the clinical signs of soft-tissue infection had resolved and there was no abnormal uptake of labelled WBCs. Treatment was otherwise continued for a total of 12 weeks and then discontinued. For these individuals, another WBC-SPECT/CT was performed at 12 weeks. Remission was defined as the absence of recurrence of osteomyelitis at the same location at 1 year.

Results: Forty-five individuals were included; overall remission rate was 84% at 1 year. A 6 week course of antibiotics was used in 23 participants, 22 of whom were in remission at 1 year (96%); a 12 week course was used for 22 participants, 16 of whom were in remission at 1 year (73%). Sensitivity of WBC-SPECT/CT at 12 weeks was 100%, specificity 56%, positive predictive value 46% and negative predictive value 100%.

Conclusions/interpretation: The study suggests that WBC-SPECT/CT could predict remission at the end of antibiotic treatment.

Trial registration: ClinicalTrials.gov NCT02927678.

Keywords: Diabetic foot; Nuclear imaging; Osteomyelitis; Single photon emission computed tomography/computed tomography; Treatment.

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use*
  • Diabetic Foot / drug therapy*
  • Diabetic Foot / metabolism*
  • Female
  • Humans
  • Leukocytes / metabolism*
  • Male
  • Middle Aged
  • Osteomyelitis / drug therapy*
  • Osteomyelitis / metabolism*
  • Prospective Studies
  • Tomography, Emission-Computed, Single-Photon / methods

Substances

  • Anti-Bacterial Agents

Associated data

  • ClinicalTrials.gov/NCT02927678